期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
仙方活命饮加减治疗糖尿病足36例临床观察 被引量:12
1
作者 邓伟明 钟秀驰 +1 位作者 简小兵 戴莲仪 《四川中医》 北大核心 2006年第5期68-69,共2页
目的:探讨仙方活命饮加减治疗糖尿病足的临床疗效。方法:将71例患者随机分为治疗组和对照组,均给予基础治疗和局部治疗,在此基础上,治疗组服用仙方活命饮加减。治疗前后查空腹血糖、餐后2小时血糖,测量溃疡面积,比较治疗前后代谢状况和... 目的:探讨仙方活命饮加减治疗糖尿病足的临床疗效。方法:将71例患者随机分为治疗组和对照组,均给予基础治疗和局部治疗,在此基础上,治疗组服用仙方活命饮加减。治疗前后查空腹血糖、餐后2小时血糖,测量溃疡面积,比较治疗前后代谢状况和溃疡愈合情况。结果:治疗组痊愈率25.00%,显效率36.11%,有效率36.11%,总有效率97.22%,与对照组比较有统计学意义(P<0.05);两组治疗前后自身对照,溃疡面积和空腹血糖、餐后2小时血糖比较均有显著性差异(均P<0.01);组间比较空腹血糖、餐后2小时血糖无显著差异,溃疡面积比较有显著性差异(P<0.05)。结论:以仙方活命饮加减对瘀热互结型糖尿病足进行中西医结合治疗效果优于单用基础治疗。 展开更多
关键词 糖尿痛足 中西医结合治疗 活命饮基础治疗
下载PDF
中医药治疗代偿期乙型肝炎肝硬变的研究进展 被引量:2
2
作者 石玲 《河南中医》 2011年第9期996-998,共3页
中医药治疗代偿期乙型肝炎肝硬变具有改善肝功能、扩张肝内血管、增加肝血流量、促进肝细胞再生、抑制纤维结缔组织再生及溶解纤维组织、提高机体免疫力等作用,且安全可靠,疗效持续稳定。但辨证分型方案临床缺乏统一认识,缺乏客观的量... 中医药治疗代偿期乙型肝炎肝硬变具有改善肝功能、扩张肝内血管、增加肝血流量、促进肝细胞再生、抑制纤维结缔组织再生及溶解纤维组织、提高机体免疫力等作用,且安全可靠,疗效持续稳定。但辨证分型方案临床缺乏统一认识,缺乏客观的量化指标及疗效评定标准。 展开更多
关键词 代偿期乙型肝炎肝硬变 辨证论治 基础方治疗 中成药治疗 单味药物治疗
下载PDF
中医治疗抑郁症概述 被引量:15
3
作者 宋国新 韦志强 《河南中医》 2014年第4期776-778,共3页
目的:探讨中医药治疗抑郁症的研究现状,为今后抑郁症的深入研究提供理论依据。方法:通过查阅近5 a抑郁症的中医药治疗的相关著作与文献,从三因制宜的角度对中医药治疗抑郁症进行总结。结果:研究发现中医药在治疗抑郁症方面具有肯定的疗... 目的:探讨中医药治疗抑郁症的研究现状,为今后抑郁症的深入研究提供理论依据。方法:通过查阅近5 a抑郁症的中医药治疗的相关著作与文献,从三因制宜的角度对中医药治疗抑郁症进行总结。结果:研究发现中医药在治疗抑郁症方面具有肯定的疗效。结论:中医药对抑郁症的治疗较西医具有副反应少、提高患者生活质量、患者依从性好等明显优势,但结合地域、季节、体质的治疗方法有待研究。 展开更多
关键词 抑郁症 基础加减治疗 分龄辨证治疗 辨证治疗 中西医结合治疗 针灸治疗 心理疗法
下载PDF
Efficacy of Chinese herbal medicine for lumbar disc herniation: a systematic review of randomized controlled trials 被引量:15
4
作者 Yi Luo Jian Huang +3 位作者 Lin Xu Weikang Zhao Jie Hao Zhenming Hu 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2013年第6期721-726,共6页
OBJECTIVE: This is a review of the effects of Chi- nese herbal medicine (CHM) used alone to treat lumbar disc herniation (LDH). METHORDS: A literature search of the following electronic databases from their ince... OBJECTIVE: This is a review of the effects of Chi- nese herbal medicine (CHM) used alone to treat lumbar disc herniation (LDH). METHORDS: A literature search of the following electronic databases from their inception to Febru- ary 2013 was conducted: Chinese Biomedical data- bases, Chinese National Knowledge Infrastructure, Wanfang Database, China Science and Technology Journal Database, Cochrane Library, Web of Sci- ence, MEDLINE, and EMBASE. Randomized con- trolled trials where CHM had been used to treat LDH were selected. Data extraction, quality assess- ment, and data analysis were carried out by two in- dependent reviewers. RESULTS: Of the 2415 studies identified, eight with complete data on 1146 patients were selected. The methodological quality was poor in all trials. Five studies reported that CHM was better than WesternMedicine [OR=2.81, 95% CI (1.27, 6.18); OR=3.34, 95% CI (1.92, 5.79); 0R=2.22, 95% CI (1.08, 4.57); OR= 6.67, 95% CI (1.34, 33.28); and OR=1.94, 95% CI (1.23, 3.06)]. Two studies reported that the clinical outcome was better in CHM groups than in physio- therapy and placebo groups, [OR=3.02, 9.5% CI (1.08, 8.46); and OR=2.67, 95% CI (1.26, 5.64), re- spectively], whereas one study reported no differ- ence between CHM and physiotherapy groups. One study reported that CHM resulted in higher Japanese Orthopedic Association scores [MD=7.78, 95% CI (6.67, 8.89)] than in a control group and an- other that participants treated with CHM had lower Visual Analogue Scale scores [MD=- 0.72, 95% CI ( - 0.86, 0.58)] than those in a control group. Three studies reported that the adverse effects of CHM and Western Medicine did not differ signifi- cantly [OR=0.10, 95% CI (0.01, 1.85); OR=0.19, 95% CI (0.01,4.07); and OR=O.07, 95% CI (0.00, 1.32)]. CONCLUSION: CHM may be more effective than other interventions for LDH; however, methodologi- cal weaknesses in the studies assessed in this re- view prevent a definitive conclusion. More high-quality large-scale studies are required to clar- ify this matter. 展开更多
关键词 Drugs Chinese herbal REVIEW Ran-domized controlled trial Lumbar disc disease
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部